<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180310039023N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-01-08</date_registration>
      <primary_sponsor>Yazd University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of multisensory stimulation and breast milk on intensity of pain In premature infants in examination retinopathy</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of multisensory stimulation and breast milk on intensity of pain In premature infants during examination for retinopathy screening</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/30198</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Eligible infants are selected  by Purpose-based sampling, and then assigned to one of three study groups by drawing method. The person who is unaware of the study will  pick up one of the three numbers 1, 2 and 3 from the envelope, Blinding description: For the purpose of a single-blind study, individuals who are tasked with recording heart rate, oxygen saturation, and changes in face and behavior are blinded to the groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Pain Of Examination For Retinopathy.</hc_freetext>
      <i_freetext>Intervention 1: In the intervention group, after stabilization of infant’s condition,the intervention including a multi sensory stimulation program (visual, taste, tactile, and smell stimulation)will be  performed. At ﬁrst, the infant is placed at supine position,and the hands and legs are bent as the fetal position,so that the infant could move freely.For tactile stimulation, face, upper and lower limbs of infant is  gently touched by the mother. The intervention is  performed from 15 minutes before the beginning examination until the time of examination .For visual stimulation, the infant’s mother will be  asked to look at her baby from near and try for eye communication in order to attract the infant’s attention. The intervention is  performed from 15 minutes before the beginning examination until the time of examination .For hearing stimulation, the infant’s mother will be  asked to speak with her baby gently and continuously. The intervention is performed from 15 minutes before the beginning of examination until the time of examination . lavender essential oil 2% is  used for smell stimulation. The researcher stains a piece of sterile gauze with 5 drops of  it and clamps into the infant dress .. The intervention will be performed from 15 minutes before the beginning of examination until the time of examination.1 ml of 33% glucose solution will be used for taste stimulation. glucose solution will be  drawn into a syringe by the researcher. The syringe mouth without needle  will be placed into the infant’s mouth and the solution will be injected into the infant’s mouth with gentle movements along with infant’s sucking for 30 seconds. This intervention starts  2 minutes before the examination.  The mother will be instructed by the researcher before the intervention is performed. The procedure will be followed in a coordinated and similar manner, so that all mothers will do the same. Intervention 2: Intervention group(breast milk) :  2 ml of breast milk is drawn by the researcher into the syringe in 2 minutes before examination  and poured into the baby's mouth gently for 30 seconds. Intervention 3: Control group: The control group will receive no intervention, and routine care, including incubation and Nidcap care( neonatal individualized developmental care assessment plan), will be performed by mothers and staff on a regular and unplanned basis.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is After the study is completed, it will be decided</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Khadije Dehghani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bou Ali</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8916978477</zip>
        <telephone>+98 35 3824 1751</telephone>
        <email>dehghanish@ssu.ac.ir</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Khadije Dehghani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bu Ali</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8916978477</zip>
        <telephone>+98 35 3824 1751</telephone>
        <email>dehghanish@ssu.ac.ir</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Premature neonates born with a fetal age of 32 weeks and 6 days or less, or weighing 1,500 grams or less, or babies weighing between 1500 and 2000 grams, accompanied by a period of unstable clinical conditions that lasted 4 weeks after birth
The baby is checked for the first time
The baby is fed one hour before the examination and no longer fed
The baby looks calm and alert.
Parents' written and informed consent to study
agreement of the doctor who do examine</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>1 year</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The baby has a history of surgery and cardiopulmonary resuscitation, and lung hemorrhage
Apgar 5 minutes less than 6
Painkillers have been prescribed for the baby for the past 24 hours
The baby needs to have a positive pressure and tracheal tube ventilation
The baby has abnormalities and problems with the nervous system, heart and respiratory system
Babies who should not be fed(n.p.o)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>H35.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Retinopathy of prematurity</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In the intervention group, after stabilization of infant’s condition,the intervention including a multi sensory stimulation program (visual, taste, tactile, and smell stimulation)will be  performed. At ﬁrst, the infant is placed at supine position,and the hands and legs are bent as the fetal position,so that the infant could move freely.For tactile stimulation, face, upper and lower limbs of infant is  gently touched by the mother. The intervention is  performed from 15 minutes before the beginning examination until the time of examination .For visual stimulation, the infant’s mother will be  asked to look at her baby from near and try for eye communication in order to attract the infant’s attention. The intervention is  performed from 15 minutes before the beginning examination until the time of examination .For hearing stimulation, the infant’s mother will be  asked to speak with her baby gently and continuously. The intervention is performed from 15 minutes before the beginning of examination until the time of examination . lavender essential oil 2% is  used for smell stimulation. The researcher stains a piece of sterile gauze with 5 drops of  it and clamps into the infant dress .. The intervention will be performed from 15 minutes before the beginning of examination until the time of examination.1 ml of 33% glucose solution will be used for taste stimulation. glucose solution will be  drawn into a syringe by the researcher. The syringe mouth without needle  will be placed into the infant’s mouth and the solution will be injected into the infant’s mouth with gentle movements along with infant’s sucking for 30 seconds. This intervention starts  2 minutes before the examination.  The mother will be instructed by the researcher before the intervention is performed. The procedure will be followed in a coordinated and similar manner, so that all mothers will do the same.</i_keyword>
      <i_keyword>Intervention group(breast milk) :  2 ml of breast milk is drawn by the researcher into the syringe in 2 minutes before examination  and poured into the baby's mouth gently for 30 seconds.</i_keyword>
      <i_keyword>Control group: The control group will receive no intervention, and routine care, including incubation and Nidcap care( neonatal individualized developmental care assessment plan), will be performed by mothers and staff on a regular and unplanned basis.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Intensity Of Pain. Timepoint: During Eye Examination For Retinopathy. Method of measurement: PIPP Tool.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yazd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-05-16</approval_date>
        <contact_name>National Ethics Committee for Biomedical Research</contact_name>
        <contact_address>Shahid Sadughi Yazd Yazd Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
